FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046118 [Registered on: 03/10/2022] Trial Registered Prospectively
Last Modified On: 17/10/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Behavioral 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Training to improve newborn ventilation skills using AIR device. 
Scientific Title of Study   Augmented Infant Resuscitator (AIR): Transitioning a novel behavior change innovation to drive newborn ventilation skills enhancement 
Trial Acronym  AIR 
Secondary IDs if Any  
Secondary ID  Identifier 
2013P002204b V 1.0 dated March 26, 2022  Protocol Number 
NCT05349175  ClinicalTrials.gov 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr S M Dhaded 
Designation  Professor Paediatrics 
Affiliation  J N Medical College KAHER Belagavi  
Address  Department of Paediatrics J N Medical College Nehru Nagar Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  9844232586   
Fax  918312472891  
Email  drdhadedsm@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr S M Dhaded 
Designation  Professor Paediatrics 
Affiliation  J N Medical College KAHER Belagavi  
Address  Department of Paediatrics J N Medical College Nehru Nagar Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  9844232586   
Fax  918312472891  
Email  drdhadedsm@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr S M Dhaded 
Designation  Professor Paediatrics 
Affiliation  J N Medical College KAHER Belagavi  
Address  Department of Paediatrics J N Medical College Nehru Nagar Belagavi

Belgaum
KARNATAKA
590010
India 
Phone  9844232586   
Fax  918312472891  
Email  drdhadedsm@gmail.com  
 
Source of Monetary or Material Support  
Grand Challenges Canada MaRS Centre, South Tower 101 College Street, Suite 406, Toronto, Ontario, Canada 
Mbarara University of Science and Technology, Plot No. 8-18, Kabale Road, P.O Box No. 1410, Mbarara, Uganda 
 
Primary Sponsor  
Name  Grand Challenges Canada 
Address  Grand Challenges Canada MaRS Centre, South Tower 101 College Street, Suite 406, Toronto, Ontario, Canada 
Type of Sponsor  Other [Nonprofit organization] 
 
Details of Secondary Sponsor  
Name  Address 
Mbarara University of Science and Technology  Mbarara University of Science and Technology, Plot No. 8-18, Kabale Road, P.O Box No. 1410, Mbarara, Uganda 
 
Countries of Recruitment     India
Kenya  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr S M Dhaded   Jawaharlal Nehru Medical College Belgaum   Department: Womens and Childrens Health Research Unit Institution: KLE Academy of Higher Education and Research J N Medical College, Nehru Nagar Belagavi
Belgaum
KARNATAKA 
9844232586
918312472891
drdhadedsm@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee of KLE Academy of Higher Education and Research  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Z768||Persons encountering health services in other specified circumstances,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Augmented Infant Resuscitator (AIR) device Experimental: Cohort A  Receives AIR device feedback visually from the beginning of the study till 6 months during bag-mask ventilation practice sessions at least twice a week each lasting for 5–15 minutes  
Intervention  Augmented Infant Resuscitator (AIR) device Experimental: Cohort B  Receives AIR device feedback visually from the 3rd month of the study till 6 months during bag-mask ventilation practice sessions at least twice a week each lasting for 5–15 minutes 
Intervention  Augmented Infant Resuscitator (AIR) device Experimental: Cohort C  Receives AIR device feedback visually from the 5th month of the study till 6 months during bag-mask ventilation practice sessions at least twice a week each lasting for 5–15 minutes 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Skilled Birth Attendants (SBAs) working clinically at the selected facilities (i.e., in-service providers)
2. SBAs who participate in the HBB training offered by our group at the beginning of the study
3.SBAs who demonstrate competence, after initial training, in key neonatal resuscitation skills and competencies (i.e., pass the BMV skills check and OSCE B)
4. SBAs able to adequately understand the language in which the HBB training is offered (e.g., we anticipate the trainings will be offered in English)
5. SBAs over 18 years of age
6. SBAs who provide written informed consent for participation in the study
 
 
ExclusionCriteria 
Details  1. Students or clinicians still in training (i.e., pre-service providers)
2. SBAs and other health workers who do not participate in initial HBB training
3. SBAs that are unable to adequately understand the language in which the HBB training is offered
4. SBAs under 18 years of age
5. SBAs who do not provide written informed consent for participation in the study 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1. Effective bag-mask ventilation
2. Time to effective bag-mask ventilation
3. Bag-mask ventilation skills 
Immediately after training, 2 months after training, 4 months after training, and 6 months after training 
 
Secondary Outcome  
Outcome  TimePoints 
1. Provider-level perceptions
2. Cost analysis
3. Perinatal outcomes 
Immediately after training, 2 months after training, 4 months after training, 6 months after training, and 7 months after training 
 
Target Sample Size   Total Sample Size="250"
Sample Size from India="125" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/12/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  01/12/2022 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Closed to Recruitment of Participants 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response (Others) -  Dr S M Dhaded (drdhadedsm@gmail.com), Dr. Shivaprasad S Goudar (sgoudar@jnmc.edu) and Dr. Roopa Bellad (belladroopa5@gmail.com)

  6. For how long will this data be available start date provided 01-11-2022 and end date provided 30-07-2028?
    Response - Beginning 3 months and ending 5 years following article publication.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

Background

Neonatal mortality is a significant contributor to under-five deaths. Of the 6.9 million children under 5 who die annually, more than 43% die in the first month of life. Breathing problems at the time of birth (i.e., perinatal asphyxia) account for a major portion of these deaths globally, and approximately 6 million newborns annually would avoid death or severe neurologic disability if provided effective breathing assistance (ventilation) within one minute of birth. Effective resuscitation assistance at the time of birth is lifesaving: every 30 seconds delay in establishing effective ventilation from birth increases the risk of death by 16% up to 6 minutes for newborns who have not initiated spontaneous breathing at birth. This finding emphasizes the need to establish timely Bag-Valve-Mask ventilation. However, one in five trained healthcare professionals (HCPs) fail to perform the technique correctly, and those that do, often experience a rapid decline in proficiency.  

Goal

The immediate goal of this study is to better understand the potential effectiveness of the AIR device in improving the retention of newborn ventilation skills among SBAs in Kenya and India. The ultimate goal of improving newborn ventilation skills retention will be to improve newborn resuscitative care and newborn outcomes.

Specific aims

1. To evaluate the impact of the Augmented Infant Resuscitator (AIR) device feedback on ventilations skills retention over 6 months – at baseline and at approximately 2, 4, and 6 months post-training – among skilled birth attendants (SBAs) in Kenya and India

2. To understand SBA and supervisor user experiences in the use of AIR device technology for low-dose high-frequency (LDHF) ventilation practice

3. To understand costs related to AIR device implementation and the projected costs for scaling and sustaining an AIR device program.

4. To collect site-specific, de-identified, perinatal and early neonatal mortality data as published and recorded by the Global Network for Maternal and Child Health Research in Kenya and India.

Methods

HBB training

The study will begin by training and equipping all available SBAs at the participating facilities in the Helping Babies Breathe (HBB) training curriculum. It is anticipated that these will be one-day HBB trainings. SBAs will also receive HBB Provider Guides and wall-mountable HBB action plans.

Immediately before and after training, the study teams will use the traditional HBB assessment tools (copies of these instruments are available in the shared AIR Partner Folder):

Immediately pre-training:      HBB Knowledge Assessment

                                                HBB Bag-Mask Ventilation Skills Test

                                                HBB OSCE A

                                                HBB OSCE B (with 2-minute ventilation epoch)

 Immediately post-training:    HBB Knowledge Assessment

                                                HBB Bag-Mask Ventilation Skills Test

                                                HBB OSCE A

                                                HBB OSCE B (with 2-minute ventilation epoch)

AIR device training

Training in the use of the AIR device is quite brief and will be integrated into the HBB trainings. By the end of each HBB training, we expect all providers to be familiar to AIR device use.

Study design

Eligibility

We wish to enroll all skilled birth attendants (SBAs) (approximately 12 SBAs/facility) from approximately 9-12 health facilities in Kenya and another 9-12 health facilities in India. Our goal is approximately 250 total SBAs across the two countries.

Inclusion criteria for study participants

1. SBAs working clinically at the selected facilities (i.e., in-service providers)

2. SBAs who participate in the HBB training offered by our group at the beginning of the study

3. SBAs who demonstrate competence, after initial training, in key neonatal resuscitation skills and competencies (i.e., pass the BMV skills check and OSCE B)

4. SBAs able to adequately understand the language in which the HBB training is offered (e.g., we anticipate the trainings will be offered in English)

5. SBAs over 18 years of age

6. SBAs who provide written informed consent for participation in the study

Exclusion criteria for participants

1. Students or clinicians still in training (i.e., pre-service providers)

2. SBAs and other health workers who do not participate in initial HBB training

3. SBAs that are unable to adequately understand the language in which the HBB training is offered

4. SBAs under 18 years of age

5. SBAs who do not provide written informed consent for participation in the study

For all participant SBAs, demographic characteristics, such as the SBA cadre (doctor, nurse, or midwife), gender, age range, prior neonatal resuscitation training, etc., will be collected to better contextualize the study population and permit comparative descriptions.

Randomization: Assigning geographic clusters and study cohorts

In each country, to facilitate step-wedge implementation, selected facilities should be organized into clusters geographically (e.g., a referral hospital and all if it’s referring facilities). Study teams will then use a random number generator to assign each geographic cluster to one of three different intervention time points, Cohorts A, B, and C 

Masking

Participants in Cohort A will practice with AIR devices providing visual feedback immediately post-training, while Cohorts B and C will start with AIR devices without visual feedback. Disabling feedback from the device does not compromise its recording function that collects time-stamped data on ventilation quality. Cohort B will switch to AIR device feedback at 2 months, and Cohort C will switch to AIR device feedback at 4 months. All cohorts will continue LDHF practice with AIR device feedback through up to 6 months after initial HBB training. 

AIR device training

Once assigned to receive AIR feedback, health workers will also receive AIR device training. This AIR device training will focus on device functionality, feedback interpretation and use. In addition, regular device charging plans will be solidified with each. Meanwhile, control participants will receive training on how to effectively attach the AIR device to the resuscitation bag during ventilation practice and to “log in” during these sessions.

Periodic BMV skills assessments

During the study, the study teams will conduct facility-based bag-mask ventilation (BMV) assessments at 2, 4, and 6 months. The primary outcome for this measurement will be duration and percentage of time in effective ventilation in a two-minute window after initiation of ventilation, as part of the HBB program’s existing BMV skills check or OSCE B. [TO BE DISCUSSED WITH PARTNERS: whether to have the 2-minute ventilation sessions as part of the BMV skills check, OSCE B., or a completely separate exercise.] “Effective ventilation” is defined by the cumulative time ventilating in the correct rate range without airway blockages, significant leaks, and harsh breaths and will be determined by the AIR device. Note, during these skills assessments, study participants will be evaluated with feedback turned off during the two-minute breathing epoch.

Post-training data collection will include:

2 months post-training:         HBB Bag-Mask Ventilation Skills Test

                                                HBB OSCE B (with 2-minute ventilation epoch)

 4 months post-training:         HBB Bag-Mask Ventilation Skills Test

                                                HBB OSCE B (with 2-minute ventilation epoch)

 6 months post-training:         HBB Bag-Mask Ventilation Skills Test

                                                HBB OSCE B (with 2-minute ventilation epoch)

                                                Focus group discussions / Key-informant interviews

                                                Cost analysis

Study outcomes

Primary Outcomes

1. Effective bag-mask ventilation

2. Time to effective bag-mask ventilation

3. Bag-mask ventilation skills 

Secondary Outcomes

1. Provider-level perceptions

2. Cost analysis

3. Perinatal outcomes

 
Close